| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/23/2008 | EP1914299A2 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M.bovis BCG and M.microti |
| 04/23/2008 | EP1914244A2 Method of modulating the activity of functional immune molecules |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1914239A1 Attentuated gram negative bacteria |
| 04/23/2008 | EP1913958A1 Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab |
| 04/23/2008 | EP1913957A1 Adjuvanted genetic vaccines |
| 04/23/2008 | EP1913956A1 Compositons and methods for stablizing biological molecules upon lyophilization |
| 04/23/2008 | EP1913955A1 Novel method for treating H.pylori infections |
| 04/23/2008 | EP1913952A1 Molecular determinants of myeloma bone disease and uses thereof |
| 04/23/2008 | EP1913397A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 04/23/2008 | EP1913160A2 Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy |
| 04/23/2008 | EP1913137A1 Serine beta-lactamase-like / d-aia carboxypeptidase-like protein |
| 04/23/2008 | EP1913127A2 Methods and compositions for dried cellular forms |
| 04/23/2008 | EP1913028A2 Use of antibody to m-csf |
| 04/23/2008 | EP1913027A2 M-csf specific monoclonal antibody and uses thereof |
| 04/23/2008 | EP1913023A1 Novel anticoagulant polypeptides and complex |
| 04/23/2008 | EP1913020A1 Immunogenic constructs |
| 04/23/2008 | EP1913019A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 04/23/2008 | EP1912675A2 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 04/23/2008 | EP1912674A2 Bispecific single chain fv antibody molecules and methods of use thereof |
| 04/23/2008 | EP1912673A1 Process for attaching effector molecules to proteins |
| 04/23/2008 | EP1912672A2 Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| 04/23/2008 | EP1912671A2 Beta-glucuronide-linker drug conjugates |
| 04/23/2008 | EP1912670A2 Immune response inducing preparations |
| 04/23/2008 | EP1912667A2 Concentrated protein lyophilates, methods, and uses |
| 04/23/2008 | EP1912665A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/23/2008 | EP1912513A2 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 04/23/2008 | EP1791860B1 Purification process for bacterial cytolysin |
| 04/23/2008 | EP1651265B1 Vaccine formulations comprising an oil-in-water emulsion |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1434858B1 Method for the amplification of a poxvirus under serum free conditions |
| 04/23/2008 | EP1422243B1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 04/23/2008 | EP1372712B1 Equine herpesvirus vaccine |
| 04/23/2008 | EP1284993B1 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 04/23/2008 | EP1251871B1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and as adjuvants an immunogenic oligodeoxynucleotide and a polycationic polypeptide |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1214398B1 Chimeric virus-like particles or chimeric capsomers from bpv |
| 04/23/2008 | EP0906417B1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
| 04/23/2008 | EP0804212B1 Nigella sativa as a medicinal treatment |
| 04/23/2008 | CN101166978A Metering technique for lateral flow assay devices |
| 04/23/2008 | CN101166827A Expression of proteins in plants |
| 04/23/2008 | CN101166764A 骨病症的治疗 The treatment of bone disorders |
| 04/23/2008 | CN101166763A Stabilized anti-hepatitis B (HBV) antibody formulations |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166759A T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 04/23/2008 | CN101166755A Single chain antibody with cleavable linker |
| 04/23/2008 | CN101166753A Polymer conjugates of mutated neublastin |
| 04/23/2008 | CN101166752A Compositions and methods for inhibiting white spot syndrome virus (WSSV) infection |
| 04/23/2008 | CN101166559A Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 04/23/2008 | CN101166542A KIM-1 antibodies for treatment of TH2-mediated conditions |
| 04/23/2008 | CN101165068A Monoclonal antibody for resisting HER2/ErbB2 antigen, preparation method and medicament composition thereof |
| 04/23/2008 | CN101164623A Compositions comprising viruses and methods for concentrating virus preparations |
| 04/23/2008 | CN101164617A Combination drug therapy for reducing scar tissue formation |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN101164615A BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN100383244C Method for manufacturing recombinant polyclonal proteins |
| 04/23/2008 | CN100383163C Antibody for inhibiting blood coagulation and method of use thereof |
| 04/23/2008 | CN100382845C Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/23/2008 | CA2607544A1 A pharmaceutical formulation and its use for the treatment of acquired immune deficiency syndrome (aids) and other aids related diseases and a process for its preparation |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361742 Methods and materials for treating inflammatory conditions |
| 04/22/2008 | US7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| 04/22/2008 | US7361733 Stimulation, expansion of lymphocytes; polynucleotides; genetic engineering |
| 04/22/2008 | US7361511 Comparing gene expression levels in normal and tumor cells, diagnosis, treating with an antisense oligonucleotide, and monitoring results |
| 04/22/2008 | US7361504 Culturing Anaplasma |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361475 Compositions and methods relating to colon specific genes and proteins |
| 04/22/2008 | US7361459 Antiviral inhibition of capsid proteins |
| 04/22/2008 | US7361360 Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response |
| 04/22/2008 | US7361359 Neospora caninum isolate |
| 04/22/2008 | US7361358 Treating a non-spasm caused pain with botulinum toxin |
| 04/22/2008 | US7361357 Safe mutant viral vaccines |
| 04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
| 04/22/2008 | US7361355 Mutant forms of cholera holotoxin as an adjuvant |
| 04/22/2008 | US7361354 Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses |
| 04/22/2008 | US7361353 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 04/22/2008 | US7361352 Influenza immunogen and vaccine |
| 04/22/2008 | US7361351 Therapeutic uses of rbosCD14 both as an inhibitor of activation which occurs in an acute inflammatory response and as a sensitizer of bovine mammary ductal epithelial cells resulting in leukocyte recruitment and initiation of immune response |
| 04/22/2008 | US7361350 Use of an IL-1 antagonist for treating arthritis |
| 04/22/2008 | US7361349 Immunocastration of pigs |
| 04/22/2008 | US7361348 Immunogenic glycopeptides, screening, preparation and uses |
| 04/22/2008 | US7361347 Cytotoxic CD44 antibody immunoconjugates |
| 04/22/2008 | US7361346 Therapeutic compositions that produce an immune response |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361344 Co-administration of a thrombolytic and an-anti-CD18 antibody in stroke |
| 04/22/2008 | US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 04/22/2008 | US7361342 Cancerous disease modifying antibodies |
| 04/22/2008 | US7361341 Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | US7361339 Methods for reducing morality associated with acute myocardial infarction |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
| 04/22/2008 | US7361336 Administering antibody or a fragment thereof that binds to a human homolog of frizzled, to inhibit the proliferation of cancer cells |
| 04/22/2008 | US7361334 Method of treatment of diabetes through induction of immunological tolerance |
| 04/22/2008 | US7361333 Creating tolerance to transplanted cells, tissue, or organs without the need for continuous immunosuppression. A tolerizing dose of a cell or tissue within a membrane structure is implanted into a patient. Once the patient |
| 04/22/2008 | US7361332 Alloactivated lymphocytes in a pharmaceutical excipient; immunotherapy |
| 04/22/2008 | US7361330 Generating dendritic cells from hematopoietic progenitor and stem cells; vaccine adjuvants, enhancing immune responses for treating tumor |
| 04/22/2008 | US7361329 Administering vaccine |